0001775819-20-000001.txt : 20201209 0001775819-20-000001.hdr.sgml : 20201209 20201208173207 ACCESSION NUMBER: 0001775819-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201209 DATE AS OF CHANGE: 20201208 EFFECTIVENESS DATE: 20201209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genesis Therapeutics, Inc. CENTRAL INDEX KEY: 0001775819 IRS NUMBER: 833198117 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-382629 FILM NUMBER: 201376205 BUSINESS ADDRESS: STREET 1: 1742 SAND HILL ROAD STREET 2: 207 CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 2036154567 MAIL ADDRESS: STREET 1: 1742 SAND HILL ROAD STREET 2: 207 CITY: PALO ALTO STATE: CA ZIP: 94304 D 1 primary_doc.xml X0708 D LIVE 0001775819 Genesis Therapeutics, Inc. 1860 EL CAMINO REAL SUITE 400 BURLINGAME CA CALIFORNIA 94010 203-615-4567 DELAWARE None None Corporation true 2019 EVAN FEINBERG 1860 EL CAMINO REAL SUITE 400 BURLINGAME CA CALIFORNIA 94010 Executive Officer Director LEONARD BELL 1860 EL CAMINO REAL SUITE 400 BURLINGAME CA CALIFORNIA 94010 Director PEPTIBOON PRASIT 1860 EL CAMINO REAL SUITE 400 BURLINGAME CA CALIFORNIA 94010 Director KRIS JENNER 1860 EL CAMINO REAL SUITE 400 BURLINGAME CA CALIFORNIA 94010 Director BENJAMIN SKLAROFF 1860 EL CAMINO REAL SUITE 400 BURLINGAME CA CALIFORNIA 94010 Executive Officer NICHOLAS STOCK 1860 EL CAMINO REAL SUITE 400 BURLINGAME CA CALIFORNIA 94010 Executive Officer Biotechnology Decline to Disclose 06b false 2020-11-24 false true false 0 Indefinite 49517631 Indefinite false 24 0 0 0 false Genesis Therapeutics, Inc. EVAN FEINBERG EVAN FEINBERG PRESIDENT AND CEO 2020-12-08